Constant refinement of USP and value proposition is one of the main principles of modern marketing and it has found a reflection in Market Access too. It is important for pharmaceutical and medical devices companies to know their customers’ perceptions, needs and expectations. To meet and satisfy the demand for specific information or clinical evidence and to assign a fair market price in ever changing and evolving healthcare evidence and Real World Data (RWE).
Interested to learn more about interactive health data visualizations, digital tools and communication interfaces for HEOR models ?
We welcome ISPOR participants to meet us at our booth #512. We will be presentation our latest works, budget impact and cost-effectiveness models for iPad/Web, interactive health data visualizations and tools/platforms for value story delivery and communication.
Please come by our booth if you are interested to know more !
Digital Health Outcomes team
HEOR is a field of Economic Evaluations of Healthcare Technologies
Health Economics and Outcomes Research (HEOR) is an area of economic analyses that deals with the studies and mathematical models (simulations) based on available clinical, epidemiological, economic data and published evidence to inform rational and evidence based decision making. HEOR deals with allocation of funds for healthcare purchasing, evaluations of the value for money of healthcare technologies, drugs and medical devices in order to inform budgeting and change in clinical practice decisions. Healthcare payers (government, insurance companies, hospitals) operating under constrained budgets are always seeking to maximise the output (value, health, procedures) subject to limited financial resources and other constraints (technical, time, legal, management changes).
Pharma and medical devices companies put a lot of effort into development of their product value story. The value story often takes a form of an MS Excel file or a Power Point deck containing detailed information on burden of illness, product profile, clinical differentiators and health outcomes.
The question is – do these conventional document formats communicate product value story effectively ? Most probably not. With modern digital tools Key Account Managers (KAM) and Medical Science Liaisons (MSL) can present health data and evidence to payers and healthcare providers more effectively.
Modern ways of presenting evidence, data and models in an interactive digital format. Interested to learn more? Please join us at our booth #TT3 (Concourse Level) during ISPOR in DC.
We are keen to share our experience with the cutting edge data visualisation tools and latest web techs that maximise the impact of health economic models and value story. Our experts will be happy to answer any questions you might have regarding the choice of appropriate software techs, tools and data visualisation methods.
Check out our latest blog article on best practices to data visualisation and interactive storytelling: http://bit.ly/1OzbD8i
Looking forward to seeing you at the conference !
Digital Health Outcomes team
MS Excel, SAS, SPSS, R, Stata, Matlab and other statistics and modelling software packages are of great help when it comes to model core and logic development. These tools became available in mid eighties. They are around for 30 years already, but are they good enough for communication in modern digital era?
How interactive data visualizations change communication of health data
Presentation of health data is undergoing a big change, one that will influence not only how payers and providers make their decisions but also how pharma, medical devices and in-vitro diagnostics companies will interact with external world. Five years ago, interactive health data visualisations usually took a form of simple dashboards with animated charts and accompanying messages.
Nowadays evolutions of modern web capabilities and emergence of the powerful data visualisation tools open almost unlimited possibilities to visualise data and tell the complex story in an easy to digest manner.
Modern life is undoubtedly full of data and means to generate, present, receive or transfer it. It also implies that it has become much more difficult to filter useful and important pieces of information out of general “ocean” – distinguish significant from insignificant.
Digital Health Outcomes presented publicly services and technologies at ISPOR 2016 in Milan. We’d like to thank all our partners for support and ongoing collaboration. We look forward for new opportunities in 2016 !
During a 3 day conference were were exposed to a lot of interest from the side of pharmaceutical producers and consulting sector. A lot of conference participants were interested in a new approaches to data visualisations and interactive storytelling. We appreciate the dataviz movement is growing within a healthcare and life sciences industries. Effective data communications is a crucial step in market access. Pharmaceutical producers spend millions of dollars to develop robust and strong clinical evidence, but don’t communicate findings in the most effective manner. Our role and goal is to power credible data with modern data visulaizaion appraoces tools and libraries to convey health evidence in the most effective way.
The ‘big data’ matter has lately been widely discussed within the various businesses and industries, such as IT, chemical, pharmaceutical, metallurgical, financial, oil and gas, consumer, high technology, retail etc. No wonder it even managed to create a significant hype, the promises of big data acquisitions are very tempting, but the failure rate is high as well.
We tried to analyze different researches regarding ‘big data’ and form our own opinion on the subject.